| ¿µ¹® | Parkinson disease | ÇÑ±Û | ÆÄŲ½¼º´ |
|---|---|---|---|
| ¼³¸í | ³ªÀÌµç »ç¶÷¿¡°Ô ¹ß»ýÇÏ´Â ½Å°æ°èÀÇ ÅðÇິÀÌ´Ù. ÁÖ·Î ¿îµ¿À» ´ã´çÇÏ´Â Áß°£³úºÎÀ§°¡ ħ¹üµÈ´Ù. ¿øÀÎÀº ¹ÙÀÌ·¯½º, ¾à¹°, ȤÀº µ¿¸Æ°æÈÁõ µîÀ¸·Î ¾Ë·ÁÁø °æ¿ìµµ ÀÖÀ¸³ª, ¿øÀÎÀ» ¾Ë ¼ö ¾ø´Â °æ¿ì°¡ ¸¹´Ù. Áõ»óÀº °¡¸é¾ó±¼, ¾²·¯Áú °Í °°Àº °ÉÀ½°ÉÀÌ, ¼Õ¶³¸², ±ÙÀ°ÀÇ °Á÷, ¾ÕÀ¸·Î ±â¿ï¾îÁø ÀÚ¼¼ µîÀÓ. Ä¡·á´Â Ưº°ÇÑ °ÍÀÌ ¾øÀ¸¸ç, ´ë°³ º¸Á¸Àû Ä¡·á(¿ÏÄ¡¸¦ ¸ñÀûÀ¸·Î ÇÏÁö ¾Ê°í ´ÜÁö ȯÀÚÀÇ »ýȰÀ» º¸Á¶ÇØÁÖ´Â Á¤µµÀÇ Ä¡·á)¸¦ ½ÃÇàÇÑ´Ù. ÃÖ±Ù, Á×Àº žÆÀÇ ³ú¸¦ À̽ÄÇÏ´Â ³ú À̽ļú¿¡ ÀÇÇÑ Ä¡·áÈ¿°ú°¡ ³ô´Ù´Â º¸°í°¡ ÀÖ´Ù. |
||
| ¿µ¹® | secondary infection | ÇÑ±Û | ÀÌÂ÷°¨¿° |
|---|---|---|---|
| ¼³¸í | ¾î¶² º´¿øÃ¼ÀÇ °¨¿°¿¡ ÀÇÇÏ¿© º»ÀÎÀÇ ÀúÇ×·ÂÀÌ ¾àÇØÁ³À» ¶§ ¸öÀÇ ´Ù¸¥ ºÎÀ§·Î ÀüÀÌÇÏ¿© ´Ù½Ã °¨¿°À» ÀÏÀ¸Å°´Â °Í. º´¿øÃ¼°¡ ÀÎü¿¡ ħÀÔÇÏ¿© ƯÁ¤ÇÑ ±â°üÀ̳ª Á¶Á÷¿¡¼ º´¿øÃ¼°¡ Áõ½ÄÇϰí, ±×°÷¿¡ ƯÀ¯ÀÇ º´Å͸¦ ÀÏÀ¸Å°´Â °ÍÀÌ 1Â÷°¨¿° ¶Ç´Â Ãʰ¨¿°ÀÌ´Ù. ÀÌ 1Â÷°¨¿°ÀÇ º´ÅÍÀÇ º´¿øÃ¼°¡ Ç÷°ü-¸²ÇÁ°ü-±â°ü-¼ÒȰü-¿ä°ü µîÀÇ ±æÀ» µû¶ó °°Àº ±â°üÀÇ ´Ù¸¥ ºÎÀ§³ª ´Ù¸¥ ±â°üÀ¸·Î ¿î¹ÝµÇ¾î °¨¿°À» ÀÏÀ¸Å²´Ù. µû¶ó¼ 1Â÷°¨¿°¿¡ ÀÇÇÏ¿© ÃæºÐÇÑ ¸é¿ªÀÌ µÉ °æ¿ì¿¡´Â 2Â÷°¨¿°ÀÌ ÀϾÁö ¾Ê´Â´Ù. ¿¹¸¦ µé¾î, À¯Ç༺ °¨±â¿¡ °É·ÈÀ» ¶§ ¼¼±Õ¿¡ ÀÇÇÑ Æó·ÅÀÌ µÚµû¸£´Â °æ¿ì¸¦ À̸¥´Ù. Æó·Å±Õ, ȳó¾Ë±Õ, ´ëÀå±Õ µûÀ§°¡ ÀÖ´Ù. |
||
| ¿µ¹® | infectious disease | ÇÑ±Û | °¨¿°º´ |
|---|---|---|---|
| ¼³¸í | ¹ÙÀÌ·¯½º·ÎºÎÅÍ ±â»ýÃæ Å©±â±îÁöÀÇ »ý¹°À» ¿øÀÎÀ¸·Î ÇÏ´Â º´. ¿øÀÎÀº Á¢ÃËÀü¿°¼ºÀ̸ç, º´¿ø¿¡¼ °¨¿°µÇ´Â °æ¿ìµµ ÀÖ´Ù. °¨¿°À» ¿øÀαտ¡ µû¶ó ºÐ·ùÇÏ¸é ¹ÙÀÌ·¯½º, ¼¼±Õ, Ŭ¶ó¹Ìµð¾Æ, ¸®ÄÏÂ÷, ¹ÌÄÚ¹ÚÅ׸®¿ò, °õÆÎÀÌ, ¿øÃæ, À±Ãæ, ¿ÜºÎ±â»ýÃæ °¨¿°À¸·Î ³ª´ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | hypertensive heart disease | ÇÑ±Û | °íÇ÷¾Ð½ÉÀ庴 |
|---|---|---|---|
| ¼³¸í | °íÇ÷¾Ð¿¡ ÀÇÇØ¼ »ý±â´Â ½ÉÀ庴. °íÇ÷¾Ð½ÉÀ庴À̶ó´Â Áø´ÜÀ» ºÙÀ̱â À§Çؼ´Â ÃÖ¼ÒÇÑ ´ÙÀ½°ú °°Àº Á¶°ÇÀÌ ºÎÇյǾî¾ß Çϴµ¥, ù° ½ÉÀåÇ÷°ü°è¿¡ ½ÉÀ庴À» À¯¹ßÇÒ ¼ö ÀÖÀ» ¸¸ÇÑ ´Ù¸¥ º´º¯ÀÌ ¾øÀÌ ÁÂ½É½Ç ºñ´ë°¡ ÀÖ¾î¾ß Çϸç, µÑ° °íÇ÷¾ÐÀ» ¾Î¾Ò´Ù´Â º´·ÂÀÌ ÀÖ¾î¾ß ÇÑ´Ù. ÁÖ·Î °íÇ÷¾Ð¿¡ ÀÇÇÑ ½ÉÀ庴Àº Ãʱ⿡´Â Á½ɽÇÀÌ ºñÈĶó´Â °ÍÀ¸·Î Ư¡µÇ¾îÁø´Ù. Áï Ç÷¾ÐÀÌ ³ôÀ¸¹Ç·Î Ç÷¾×À» ¼øÈ¯½Ã۱â À§Çؼ´Â ±×¸¸Å ½ÉÀåÀÇ Ç÷¾×À» º¸³»´Â ÈûÀÌ ÁÁ¾Æ¾ß ÇÑ´Ù. ±× ÈûÀ» ¾ò±âÀ§Çؼ´Â ½É±ÙÀÇ ºñÈİ¡ ÇÊ¿ä·Î ÇÏ¿© ÁÂ½É½Ç ±ÙÀ°ÀÇ ºñÈİ¡ »ý±ä´Ù. ±×¸®°í °íÇ÷¾ÐÀÌ Áö¼ÓÀÌ µÉ °æ¿ì¿¡´Â °á±¹ ½ÉÀåÀÌ Á¦ ±¸½ÇÀ» ÇÏÁö ¸øÇÏ°í ÆßÇÁ·Î¼ÀÇ ±â´ÉÀ» ÀÒ¾î¹ö¸®°Ô µÇ¾î ½ÉÀå±â´É»ó½Ç¿¡ ºüÁö°Ô µÈ´Ù. |
||
| ¿µ¹® | pelvic inflammatory disease | ÇÑ±Û | °ñ¹Ý¿°Áúȯ |
|---|---|---|---|
| ¼³¸í | °ñ¹ÝÁÖÀ§ÀÇ Àå±â¿¡ ¹ß»ýÇÏ´Â ¿°ÁõÀ» ¸»ÇÔ. ÁÖ·Î ¿©¼º¿¡¼ ¹ß»ýÇÏ¸ç ¿øÀÎÀº ÀÓ±Õ(gonococcus)°ú ºñÀÓ±Õ¿¡ ÀÇÇÑ °¨¿°(non-gonorrheal infection)¿¡ ÀÇÇÑ´Ù. Áõ»óÀº Ãʱ⿡´Â ÁúºÐºñ¹°, ÇϺ¹ºÎµ¿Åë, ¿©¼ºÀÇ »ý½Ä±âºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¾ÐÅë, ¿ù°æÅë, ¿ù°æ·®ÀÇ Áõ°¡ µîÀÌ´Ù. ÀÏÂï Ä¡·áÇØ¾ß Çϸç, °è¼ÓÀûÀ¸·Î º´ÀÌ Áö¼Ó½Ã ¿©¼ºÀÇ ºÒÀÓÀÇ ¿øÀÎÀÌ µÈ´Ù. ÈÄÁø±¹¿¡¼´Â °¡Àå ¸¹Àº ¿©¼ººÒÀÓÀÇ ¿øÀÎÀ̱⵵ ÇÔ. Ä¡·á´Â Ç×»ýÁ¦ÀÇ Åõ¿©ÀÌ´Ù. |
||
| PD | Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p... |
|---|---|
| SA | salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame... |
| ECG | Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ = EKG 1. Conducting System Structu... |
| CD | cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise... |
| HD | Haab-Dimmer [syndrome]; Hajna-Damon [broth]; Hansen disease; hearing distance; heart disease; helix ... |
| IPD | Idiopathic Parkinson's disease |
|---|---|
| PD | Parkinson Disease |
| PDQ-39 | Parkinson's Disease Questionnaire |
| UPDRS | Unified Parkinson Disease Rating Scale |
| PD | Parkinson |
Kugelberg-Welander disease ±Ù À§ÃàÁõÀÇ À¯Àü¼º ¿¬¼ÒÇüÀ¸·Î¼ º¸Åë »ó¿°»öü¼º ¿¼º ÇüÁú·Î À¯ÀüµÈ´Ù. ô¼ö Àü°¢ÀÇ º´º¯ÀÌ ±× ¿øÀÎÀÌ´Ù.
kukuruku ¿øÀÎ ºÒ¸íÀ̸ç, ³ªÀÌÁö¸®¾Æ¿¡¼ º¼ ¼ö ÀÖ´Â ÁúȯÀ¸·Î, ¿
| parkinson disease | Progressive, degenerative disease of unknown aetiology characterised by rhythmic tremor of the limbs, stooped posture, slowness of voluntary movements, and masklike facial expression. Pathologically there is nerve cell loss in the melanin-containing cells in the brainstem and a corresponding reduction in dopamine levels in the corpus striatum. Lewy bodies are present in the substantia nigra and locus coeruleus. (12 Dec 1998) |
|---|---|
| parkinson disease, postencephalitic | A form of parkinson disease due to degeneration of the corpus striatum or substantia nigra, frequently occurring as a sequel of lethargic encephalitis. The early age of onset, the rapid progression of symptoms and signs of stabilization, and the presence of a variety of other neurological disorders (sociopathic behaviour, tics, spasms, oculogyric crises and other restricted motor disorders, breathing arrhythmias, hyperphagia, and bizarre movements, postures, and gaits) distinguish this disease from the one described by parkinson. (12 Dec 1998) |
| parkinson disease, symptomatic | Symptoms of parkinson disease induced by drugs, or following cerebral arteriosclerosis, brain tumour, or other central nervous system disorders except encephalitis, which is parkinson disease, postencephalitic. (12 Dec 1998) |
| Parkinson's disease | <neurology> A progressive, neurological disease first described in 1817 by James Parkinson. The pathology is not completely understood, but there appears to be consistent changes in the melanin-containing nerve cells in the brainstem (substantia nigra, locus coeruleus), where there are varying degrees of nerve cell loss with reactive gliosis along with eosinophilic intracytoplasmic inclusions (Lewy bodies). Biochemical studies have shown below normal levels of dopamine in the caudate nucleus and putamen. Symptoms include shuffling gait, stooped posture, resting tremor, speech impediments, movement difficulties and an eventual slowing of mental processes and dementia. (27 Sep 1997) |
| disease, parkinson's | An abnormal condition of the nervous system caused by degeneration of an area of the brain called the basal ganglia. The disease results in rigidity of the muscles, slow body movement and tremor. Parkinson's disease is also called paralysis agitans and shaking palsy. (12 Dec 1998) |
| Parkinson, James | <person> This English physician is chiefly remembered for his 66-page "Essay on the Shaking Palsy" (first edition is valued at |
| Parkinson's facies | The expressionless or masklike facies characteristic of parkinsonism. Synonym: masklike face. (05 Mar 2000) |
| Parkinson, Sir John | <person> British cardiologist, *1885. See: Wolff-Parkinson-White syndrome. (05 Mar 2000) |
| wolff-parkinson-white syndrome | <syndrome> A form of pre-excitation characterised by a short pr interval and a long qrs interval with a delta wave. (12 Dec 1998) |
| Wolf Parkinson White syndrome | <cardiology, syndrome> Abnormal cardiac conduction that occurs by way of an accessory pathway between the atria and the ventricles. Baseline ECG will typically show a short P-R interval and a slurred upstroke of the QRS (delta wave). Tachyarrhythmias are common. (27 Sep 1997) |
| James Parkinson | <person> This English physician is chiefly remembered for his 66-page "Essay on the Shaking Palsy" (first edition is valued at |
| secondary disease | A disease that follows and results from an earlier disease, injury, or event, a wasting disorder that follows successful transplantation of bone marrow into a lethally irradiated host; frequently severe and usually associated with fever, anorexia, diarrhoea, dermatitis, and desquamation. See: graft versus host disease. (05 Mar 2000) |
| CS2 secondary alkylsulfohydrolase | <enzyme> From comamonas terrigena Registry number: EC 3.1.6.- Synonym: cs2 sa sulfohydrolase (26 Jun 1999) |
| protein structure, secondary | The stage in the development of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices and beta sheets. This is the first folding level of protein building. (12 Dec 1998) |
| secondary | Second or inferior in order of time, place or importance, derived from or consequent to a primary event or thing. Origin: L. Secundarius, secundus = second (18 Nov 1997) |
Synonyms : Parkinson Disease, Secondary Vascular, Parkinson Disease, Symptomatic, Parkinsonism, Secondary, Parkinsonism, Symptomatic, Secondary Vascular Parkinson Disease, Parkinsonism, Atherosclerotic, Secondary Parkinson Disease, Symptomatic Parkinsonism
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|